Aspirin and heparin in acute ischaemic stroke in older patients

Drugs and Aging

Volumn 15, Issue 1, 1999, Pages 29-36

  Gubitz, Gordon J ^a   Sandercock, Peter A G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN;

AGED; BRAIN ARTERY; BRAIN EMBOLISM; BRAIN HEMORRHAGE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG CHOICE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; NEUROPROTECTION; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REVIEW; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANTICOAGULANTS; ASPIRIN; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; GERIATRICS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 0032801195     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199915010-00003     Document Type: Review

References (33)

1. 1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease study. Lancet 1997; 349: 1269-76
2. 2. Bonita R. Epidemiology of stroke. Lancet 1992; 339 (8789) 342-4
3. 3. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project, 1981-1986: I. Methodology, demography and incident cases of first ever stroke. J Neurol Neurosurg Psychiatry 1988; 51: 1373-80
4. 4. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project, 1981-1986. J Neurol Neurosurg Psychiatry 1990; 53: 16-22
5. 5. Bamford J, Dennis M, Sandercock P, et al. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry 1990; 53: 824-9
6. 6. Wade DT. Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry 1988; 52: 236-41
7. 7. Bergman L, van de Meulen JHP, Limburg M, et al. Costs of medical care after first-ever stroke in the Netherlands. Stroke 1995; 26: 1830-6
8. 8. Stroke Unit Trialists Collaboration. Organised inpatient (stroke unit) care for stroke: Cochrane review. In: The Cochrane Library. Issue I. Oxford: Update Software Ltd., 1999
9. 9. Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997; 350: 607-14
10. 10. Fontanarosa P, Winker M. Timely and appropriate treatment for acute stroke: whats missing from this picture. JAMA 1998; 279: 1307-8
11. 11. The Royal College of Physicians of Edinburgh. Royal College of Physicians of Edinburgh consensus conference on medical management of stroke, 26 and 27 May 1998. J Neurol Neurosurg Psychiatry 1999; 66 (1): 128-9
12. 12. The European Ad Hoc Consensus Group. Neuroprotection as initial therapy in acute stroke. Cerebrovasc Dis 1998; 8: 59-72
13. 13. Cochrane Stroke Group. Collaborative review group search strategy. In: The Cochrane Library. Issue I. Oxford: Update Software Ltd, 1999
14. 14. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330: 1287-94
15. 15. Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308: 235-46
16. 16. Gubitz G, Sandercock P, Counsell C. Antiplatelet therapy for acute ischaemic stroke: Cochrane review. In: The Cochrane Library. Issue 2. Oxford: Update Software Ltd, 1999
17. 17. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, heparin, both or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-81
18. 18. Chinese Acute Stroke Trial (CAST) Collaborative Group. CAST: Randomised placebo controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641-9
19. 19. Multicentre Acute Stroke Trial - Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995; 346: 1509-14
20. 20. Warlow CP, Dennis MS, van Gijn J, et al. In: Warlow CP, Dennis MS, van Gijn J, et al. (editors). Stroke: a practical guide to management. Oxford: Blackwell Science, 1996: 550
21. 21. Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106
22. 22. Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with stroke 1: assessment, investigation, immediate management and secondary prevention [online]. Available from: URL: http: //www.pc47.cee.hw.ac.uk/sign/home.htm
23. 23. Slattery J, Warlow CP, Shorrock CJ, et al. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin: analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995; 37: 509-11
24. 24. Rosenberg RD, Bauer KA. The heparin-antithrombin system: a natural anticoagulant mechanism. In: Colman RW, Hirsh J, Marder VJ, et al., editors. Hemostasis and thrombosis: basic principles and clinical practice. 3rd ed. Philadelphia: JB Lippincott Co., 1994: 837-60
25. 25. Sandercock PA, van den Belt AG, Lindley RI, et al. Antithrombotic therapy in acute ischaemic stroke: an overview of the randomised trials. J Neurol Neurosurg Psychiatry 1993; 56: 17-25
26. 26. Gubitz G, Sandercock P, Counsell C, et al. Anticoagulants for acute ischaemic stroke: Cochrane review. In: The Cochrane Library. Issue 2. Oxford: Update Software Ltd, 1999
27. 27. Hakim AM, Furlan AJ, Hart RG, The Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 1983; 14: 668-76
28. 28. Duke RJ, Bloch RF, Turpie AGG, et al. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med 1986; 105: 825-8
29. 29. Kay R, Wong KS, Lu YL, et al. The Fraxiparine in Ischaemic Stroke Study (FISS) trial: low molecular weight heparin for the treatment of acute stroke. N Engl J Med 1995; 333: 1588-93
30. 30. Hommel M, for the FISS-bis Investigators Group. Fraxiparine in Ischaemic Stroke Study (FISS-bis) [abstract]. Cerebrovasc Dis 1998; 8 Suppl. 4: 19
31. 31. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid ORG 10172 (danaparoid), and outcome after acute ischaemic stroke. JAMA 1998; 279: 1265-72
32. 32. Gubitz G, Sandercock P, Counsell C. Different doses of anticoagutants for acute ischaemic stroke: Cochrane review protocol. In press
33. 33. Wells PS, Lensing AWA, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism: a meta-analysis. Arch Intern Med 1994; 154: 67-72